Literature DB >> 16376156

The end of the beginning: oncolytic virotherapy achieves clinical proof-of-concept.

.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 16376156     DOI： 10.1016/j.ymthe.2005.12.005

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  4 in total

Review 1.  Current issues and future directions of oncolytic adenoviruses.

Authors:  Masato Yamamoto; David T Curiel
Journal:  Mol Ther       Date:  2009-11-24       Impact factor: 11.454

Review 2.  Oncolytic virotherapy for urological cancers.

Authors:  Zahid Delwar; Kaixin Zhang; Paul S Rennie; William Jia
Journal:  Nat Rev Urol       Date:  2016-05-24       Impact factor: 14.432

Review 3.  Oncolytic viruses in head and neck cancer: a new ray of hope in the management protocol.

Authors:  Ps Shilpa; R Kaul; S Bhat; N Sultana; P Pandeshwar
Journal:  Ann Med Health Sci Res       Date:  2014-09

Review 4.  On the potential of oncolytic virotherapy for the treatment of canine cancers.

Authors:  Amy L MacNeill
Journal:  Oncolytic Virother       Date:  2015-08-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.